Covid-19 Startups : BioNTech and Moderna

Yesterday I posted about Airbnb IPO filing here and in a few weeks or months I will update my 600-startup cap. tables to 700. A major upgrade. In the mean time, even if I am not a specialist at all of biotechnology I study some startups of the field from time to time. You can check the tag #biotech for example or a post about Crispr startups. It would have been difficult not to notice recently two other startups which went public recently, Moderna in 2018 and BioNTech in 2019, because of Covid19. Look at their recent stock history when they annouced a vaccine against the virus:

Maybe have a quick look at their cap. table below but first some comments: Moderna had been founded in the Boston area in 2009 and BioNTech in Germany in 2008. Their revenues (and losses) were large at time of filing. A lot of venture capital (which owns 60% of both startups), many employees. Not young founders (46 and 60 at Moderna, 41, 43 and 64 at BioNTech). You can add any comment you want, if any…

In reality, these figures are not that different from those of the giants of the digital world in yesterday’s post, except one maybe, the founders’ age.

2 thoughts on “Covid-19 Startups : BioNTech and Moderna

  1. Hervé

    An interesting question on LinkedIn from my friend Jordi: How to explain the difference in market cap? I had not really noticed and it could be the continental divide… the advantage of being an American company vs being European

    Reply

Leave a Reply

Your email address will not be published.

Time limit is exhausted. Please reload CAPTCHA.

This site uses Akismet to reduce spam. Learn how your comment data is processed.